Cargando…

Helicobacter pylori: Commensal, symbiont or pathogen?

This review considers the data on Helicobacter pylori (H. pylori), which have been accumulated over 40 years since its description as an etiological factor in gastrointestinal diseases. The majority of modern publications are devoted to the study of the pathogenic properties of the microorganism in...

Descripción completa

Detalles Bibliográficos
Autores principales: Reshetnyak, Vasiliy Ivanovich, Burmistrov, Alexandr Igorevich, Maev, Igor Veniaminovich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901052/
https://www.ncbi.nlm.nih.gov/pubmed/33642828
http://dx.doi.org/10.3748/wjg.v27.i7.545
_version_ 1783654326184443904
author Reshetnyak, Vasiliy Ivanovich
Burmistrov, Alexandr Igorevich
Maev, Igor Veniaminovich
author_facet Reshetnyak, Vasiliy Ivanovich
Burmistrov, Alexandr Igorevich
Maev, Igor Veniaminovich
author_sort Reshetnyak, Vasiliy Ivanovich
collection PubMed
description This review considers the data on Helicobacter pylori (H. pylori), which have been accumulated over 40 years since its description as an etiological factor in gastrointestinal diseases. The majority of modern publications are devoted to the study of the pathogenic properties of the microorganism in the development of chronic gastritis, peptic ulcer disease, and gastric cancer, as well as methods for its eradication. However, in recent years, there have been more and more studies which have suggested that H. pylori has a beneficial, or potentially positive, effect on the human body. The authors have attempted to objectively analyze the information accumulated in the literature on H. pylori. Some studies consider it as one of the recently identified human bacterial pathogens, and special attention is paid to the evidence suggesting that it is probably part of the composition of the human microbiome as a commensal (commensal from French to English is a table companion) or even a symbiont. The presented data discussing the presence or absence of the effect of H. pylori on human health suggest that there is an apparent ambiguity of the problem. The re-assessment of the data available on H. pylori infection is important in order to answer the question of whether it is necessary to create a program of mass H. pylori eradication or to apply a more personalized approach to treating patients with H. pylori-associated gastrointestinal diseases and to perform eradication therapy.
format Online
Article
Text
id pubmed-7901052
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-79010522021-02-26 Helicobacter pylori: Commensal, symbiont or pathogen? Reshetnyak, Vasiliy Ivanovich Burmistrov, Alexandr Igorevich Maev, Igor Veniaminovich World J Gastroenterol Review This review considers the data on Helicobacter pylori (H. pylori), which have been accumulated over 40 years since its description as an etiological factor in gastrointestinal diseases. The majority of modern publications are devoted to the study of the pathogenic properties of the microorganism in the development of chronic gastritis, peptic ulcer disease, and gastric cancer, as well as methods for its eradication. However, in recent years, there have been more and more studies which have suggested that H. pylori has a beneficial, or potentially positive, effect on the human body. The authors have attempted to objectively analyze the information accumulated in the literature on H. pylori. Some studies consider it as one of the recently identified human bacterial pathogens, and special attention is paid to the evidence suggesting that it is probably part of the composition of the human microbiome as a commensal (commensal from French to English is a table companion) or even a symbiont. The presented data discussing the presence or absence of the effect of H. pylori on human health suggest that there is an apparent ambiguity of the problem. The re-assessment of the data available on H. pylori infection is important in order to answer the question of whether it is necessary to create a program of mass H. pylori eradication or to apply a more personalized approach to treating patients with H. pylori-associated gastrointestinal diseases and to perform eradication therapy. Baishideng Publishing Group Inc 2021-02-21 2021-02-21 /pmc/articles/PMC7901052/ /pubmed/33642828 http://dx.doi.org/10.3748/wjg.v27.i7.545 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Review
Reshetnyak, Vasiliy Ivanovich
Burmistrov, Alexandr Igorevich
Maev, Igor Veniaminovich
Helicobacter pylori: Commensal, symbiont or pathogen?
title Helicobacter pylori: Commensal, symbiont or pathogen?
title_full Helicobacter pylori: Commensal, symbiont or pathogen?
title_fullStr Helicobacter pylori: Commensal, symbiont or pathogen?
title_full_unstemmed Helicobacter pylori: Commensal, symbiont or pathogen?
title_short Helicobacter pylori: Commensal, symbiont or pathogen?
title_sort helicobacter pylori: commensal, symbiont or pathogen?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901052/
https://www.ncbi.nlm.nih.gov/pubmed/33642828
http://dx.doi.org/10.3748/wjg.v27.i7.545
work_keys_str_mv AT reshetnyakvasiliyivanovich helicobacterpyloricommensalsymbiontorpathogen
AT burmistrovalexandrigorevich helicobacterpyloricommensalsymbiontorpathogen
AT maevigorveniaminovich helicobacterpyloricommensalsymbiontorpathogen